Anti-Hepatocellular Carcinoma Effect and Molecular Mechanism of the Estrogen Signaling Pathway
There are significant gender differences in the incidence and mortality of hepatocellular carcinoma (HCC). Compared with men, the incidence and mortality of HCC in women are relatively low. The estrogen signaling pathway, composed of estrogen and estrogen receptors, has been postulated to have a pro...
Main Authors: | Yusheng Guo, Guohui Wu, Junrong Yi, Qin Yang, Wengong Jiang, Shaoqiang Lin, Xiaorong Yang, Xiangsheng Cai, Liufeng Mao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.763539/full |
Similar Items
-
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma
by: Riccardo Nevola, et al.
Published: (2023-07-01) -
Signal Pathway of Estrogen and Estrogen Receptor in the Development of Thyroid Cancer
by: Jian Liu, et al.
Published: (2021-04-01) -
Estrogens in Hepatocellular Carcinoma: Friends or Foes?
by: Giuseppe Carruba
Published: (2021-04-01) -
G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer
by: Shen Xu, et al.
Published: (2019-10-01) -
Role of estrogen receptors in health and disease
by: Peng Chen, et al.
Published: (2022-08-01)